We are live on ! Find out more
PXMD

PaxMedica, Inc. Common Stock
PXMD

Delisted

PXMD was delisted on the 1st of May, 2024.

Back to rankings

9 hedge funds and large institutions have $84.2K invested in PaxMedica, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

13% less capital invested

Capital invested by funds: $96.7K → $84.2K (-$12.6K)

25% less funds holding

Funds holding: 12 → 9 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
9
Holders Change
-3
Holders Change %
-25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$131K
2
Citadel Advisors
Citadel Advisors
Florida
+$64.8K
3
TSS
Two Sigma Securities
New York
+$25.8K
4
TRCT
Tower Research Capital (TRC)
New York
+$14.6K
5
JP Morgan Chase
JP Morgan Chase
New York
+$13.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$28K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$15.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9.22K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$9.14K
5
State Street
State Street
Massachusetts
-$6.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$43K +$131K +56,441 New
Citadel Advisors
2
Citadel Advisors
Florida
$21.2K +$64.8K +27,973 New
TSS
3
Two Sigma Securities
New York
$8.44K +$25.8K +11,148 New
TRCT
4
Tower Research Capital (TRC)
New York
$5.11K +$14.6K +6,283 +1,354%
JP Morgan Chase
5
JP Morgan Chase
New York
$4.31K +$13.2K +5,699 New
CA
6
Clearstead Advisors
Ohio
$1.7K -$5.2K -2,245 -50%
UBS Group
7
UBS Group
Switzerland
$372 +$987 +426 +655%
Osaic Holdings
8
Osaic Holdings
Arizona
$43 -$139 -60 -51%
Wells Fargo
9
Wells Fargo
California
$2 – – –
Renaissance Technologies
10
Renaissance Technologies
New York
– -$28K -5,712 Closed
Vanguard Group
11
Vanguard Group
Pennsylvania
– -$15.7K -3,233 Closed
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
– -$9.22K -1,826 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$9.14K -1,811 Closed
State Street
14
State Street
Massachusetts
– -$6.5K -1,288 Closed
HF
15
HRT Financial
New York
– -$3K -634 Closed
Bank of America
16
Bank of America
North Carolina
– -$143 -29 Closed

PXMD Hedge Fund Activity: Q4 2023 in Review

9 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in PaxMedica, Inc. Common Stock (PXMD) for Q4 2023, worth a combined $84.2K — down 13% from $96.7K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PXMD and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $131K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $28K sold.

  • 9 institutional investors held PaxMedica, Inc. Common Stock (PXMD) as of Q4 2023, down from 12 in Q3 2023.
  • Funds reported $84.2K of PaxMedica, Inc. Common Stock stock for Q4 2023, down 13% quarter-over-quarter.
  • 4 funds opened new PaxMedica, Inc. Common Stock positions in Q4 2023 and 7 closed out, a net change of -3 holders.
  • The largest PaxMedica, Inc. Common Stock buyer in Q4 2023 was Virtu Financial, an estimated $131K added.
  • The largest PaxMedica, Inc. Common Stock seller in Q4 2023 was Renaissance Technologies, an estimated $28K sold.

Based on aggregated 13F filings for Q4 2023.